Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients

Journal of Vascular and Interventional Radiology

Volumn 28, Issue 9, 2017, Pages 1248-1254

  Tapson, Victor F ^a   Hazelton, Joshua P ^b   Myers, John ^c   Robertson, Claudia ^d   Gilani, Ramyar ^d   Dunn, Julie A ^e   Bukur, Marko ^f,g,h   Croce, Martin A ⁱ   Peick, Ann ^j   West, Sonlee ^k   Lottenberg, Lawrence ^l,m   Doucet, Jay ⁿ   Miller, Preston R ^o   Crookes, Bruce ^p   Gandhi, Rajesh R ^q,r   Croft, Chasen A ^s   Manasia, Anthony ^t   Hoey, Brian A ^u   Lieberman, Howard ^v   Guillamondegui, Oscar D ^w   Novack, Victor ^x   Piazza, Gregory ^y   Goldhaber, Samuel Z ^y   more..

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^c University of Texas Health Science Center   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e School of Medicine   (United States)

^f FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^g BELLEVUE HOSPITAL CENTER   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^j MERCY HOSPITAL   (United States)

^k UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^l St Mary's Medical Center   (United States)

^m FLORIDA ATLANTIC UNIVERSITY   (United States)

ⁿ UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^o WAKE FOREST BAPTIST HEALTH   (United States)

^p MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^q JOHN PETER SMITH HOSPITAL   (United States)

^r UNIVERSITY OF NORTH TEXAS   (United States)

^s UNIVERSITY OF FLORIDA HEALTH   (United States)

^t MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^u ST LUKE S UNIVERSITY HEALTH NETWORK   (United States)

^v JACKSON MEMORIAL HOSPITAL   (United States)

^w VANDERBILT UNIVERSITY   (United States)

^x BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^y BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CATHETER DISLOCATION; CATHETER REMOVAL; CATHETER SHEATH; CATHETER THROMBOSIS; CAVOGRAPHY; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COMPRESSION STOCKING; COMPRESSION THERAPY; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DEVICE SAFETY; ECHOGRAPHY; FEMALE; HEAD INJURY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMATIC TOOL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINE INJURY; VASCULAR GUIDE WIRE; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; ADVERSE DEVICE EFFECT; CLINICAL TRIAL; COMPLICATION; CRITICAL ILLNESS; DEVICE REMOVAL; FLUOROSCOPY; INJURY; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; CENTRAL VENOUS CATHETERS; CRITICAL ILLNESS; DEVICE REMOVAL; EQUIPMENT SAFETY; FEMALE; FLUOROSCOPY; HUMANS; INTENSIVE CARE UNITS; MALE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES; VENA CAVA FILTERS; WOUNDS AND INJURIES;

EID: 85020911354     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2017.05.001     Document Type: Article

References (27)

1. Centers for the Disease Control and Prevention. Injury Prevention and Control. Fatal injury data. 2015. Available at: http://www.cdc.gov/injury/wisqars/fatal.html. Accessed January 10, 2016.
2. Brakenridge, S.C., Toomay, S.M., Sheng, J.L., Gentilello, L.M., Shafi, S., Predictors of early versus late timing of pulmonary embolus after traumatic injury. Am J Surg 201 (2011), 209–215.
3. Geerts, W.H., Jay, R.M., Code, K.I., et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335 (1996), 701–707.
4. Cohen, A.T., Tapson, V.F., Bergmann, J.F., et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371 (2008), 387–394.
5. Gould, M.K., Garcia, D.A., Wren, S.M., et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141 (2012), e227S–e277S.
6. Droege, M.E., Mueller, E.W., Besl, K.M., et al. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg 76 (2014), 450–456.
7. Louis, S.G., Van, P.Y., Riha, G.M., et al. Thromboelastogram-guided enoxaparin dosing does not confer protection from deep venous thrombosis: a randomized controlled pilot trial. J Trauma Acute Care Surg 76 (2014), 937–942 discussion 942–943.
8. Van Haren, R.M., Valle, E.J., Thorson, C.M., et al. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg 76 (2014), 443–449.
9. Decousus, H., Leizorovicz, A., Parent, F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338 (1998), 409–415.
10. Muriel, A., Jimenez, D., Aujesky, D., et al. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol 63 (2014), 1675–1683.
11. Stein, P.D., Matta, F., Keyes, D.C., Willyerd, G.L., Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism. Am J Med 125 (2012), 478–484.
12. Haut, E.R., Garcia, L.J., Shihab, H.M., et al. The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. JAMA Surg 149 (2014), 194–202.
13. Velmahos, G.C., Kern, J., Chan, L.S., Oder, D., Murray, J.A., Shekelle, P., Prevention of venous thromboembolism after injury: an evidence-based report—part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma 49 (2000), 140–144.
14. Kidane, B., Madani, A.M., Vogt, K., Girotti, M., Malthaner, R.A., Parry, N.G., The use of prophylactic inferior vena cava filters in trauma patients: a systematic review. Injury 43 (2012), 542–547.
15. Angel, L.F., Tapson, V., Galgon, R.E., Restrepo, M.I., Kaufman, J., Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol 22 (2011), 1522–1530.e3.
16. Sarosiek, S., Crowther, M., Sloan, J.M., Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med 173 (2013), 513–517.
17. US Food and Drug Administration. Removing retrievable inferior vena cava filters: FDA safety communication. 2014. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm396377.htm. Accessed January 10, 2016.
18. Konstantinides, S.V., Torbicki, A., Agnelli, G., et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35 (2014), 3033–3069 3069a–3069k.
19. Copes, W.S., Champion, H.R., Sacco, W.J., Lawnick, M.M., Keast, S.L., Bain, L.W., The Injury Severity Score revisited. J Trauma 28 (1988), 69–77.
20. US Food and Drug Administration. Design considerations for pivotal clinical investigations for medical devices—guidance for industry, clinical investigators, institutional review boards and Food and Drug Administration staff. FDA Guidance communication. Available at: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm373750.htm. Accessed January 10, 2016.
21. Fowler, R.A., Mittmann, N., Geerts, W., et al. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA 312 (2014), 2135–2145.
22. PROTECT I. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364 (2011), 1305–1314.
23. Mismetti, P., Laporte, S., Pellerin, O., et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 313 (2015), 1627–1635.
24. Geerts, W.H., Code, K.I., Jay, R.M., Chen, E., Szalai, J.P., A prospective study of venous thromboembolism after major trauma. N Engl J Med 331 (1994), 1601–1606.
25. Parienti, J.-J., Mongardon, N., Mégarbane, B., et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med 373 (2015), 1220–1229.
26. Taccone, F.S., Bunker, N., Waldmann, C., et al. A new device for the prevention of pulmonary embolism in critically ill patients: results of the European Angel Catheter Registry. J Trauma Acute Care Surg 79 (2015), 456–462.
27. Partovi, S., Davidson, J.C., Patel, I.J., Implications and limitations of the PREPIC2 study—the interventionist's perspective. Cardiovasc Diagn Ther 6 (2016), 259–261.